A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment

被引:27
作者
Annereau, J. -P. [1 ]
Brel, V. [1 ]
Dumontet, C. [4 ]
Guminski, Y. [3 ]
Imbert, T. [3 ]
Broussas, M. [2 ]
Vispe, S. [1 ]
Breand, S. [5 ]
Guilbaud, N. [1 ]
Barret, J-M. [1 ]
Bailly, C. [1 ]
机构
[1] Inst Rech Pierre Fabre, Ctr Rech Oncol Expt, F-31432 Toulouse 4, France
[2] Inst Rech Pierre Fabre, Ctr Immunol Pierre Fabre, St Julien En Genevois, France
[3] Ctr Rech Pierre Fabre, Div Chim Med, F-81106 Castres, France
[4] Univ Lyon 1, INSERM, U590, F-69365 Lyon, France
[5] Ctr Rech Pierre Fabre, Serv Informat Rech, F-81106 Castres, France
关键词
F14512; Etoposide; Biomarker; Polyamine transporter; Spermine; ETOPOSIDE; ANALOGS; CELLS; BIOSYNTHESIS; DERIVATIVES; PROBE; ACID;
D O I
10.1016/j.leukres.2009.12.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The polyamine transport system (PTS), hyperactive in cancer cells, can constitute a gate to deliver F14512, a novel spermine epipodophyllotoxin conjugate recently selected for clinical development in AML phase I. We investigated in vitro the high antiproliferative effect of F14512 against 13 leukemia cell lines, and demonstrated a statistically significant correlation with the level of PTS activity, using a novel fluorescent marker F96982. This labelling protocol was then adapted for clinical applications for blood, bone marrow and AML samples with CD45 gating. Within the patient samples, the PTS activity varied significantly in AML cells, as compared to normal lymphocytes. In conclusion, the identification of PTS-positive AML with F98982 probe offers new perspectives to select patients prone to respond to F14512. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1383 / 1389
页数:7
相关论文
共 28 条
[1]   A novel technique for visualizing the intracellular localization and distribution of transported polyamines in cultured pulmonary artery smooth muscle cells [J].
Aziz, SM ;
Yatin, M ;
Worthen, DR ;
Lipke, DW ;
Crooks, PA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (02) :307-320
[2]   F14512, a Potent Antitumor Agent Targeting Topoisomerase II Vectored into Cancer Cells via the Polyamine Transport System [J].
Barret, Jean-Marc ;
Kruczynski, Anna ;
Vispe, Stephane ;
Annereau, Jean-Philippe ;
Brel, Viviane ;
Guminski, Yves ;
Delcros, Jean-Guy ;
Lansiaux, Amelie ;
Guilbaud, Nicolas ;
Imbert, Thierry ;
Bailly, Christian .
CANCER RESEARCH, 2008, 68 (23) :9845-9853
[3]   ETOPOSIDE - CURRENT STATUS AND FUTURE PERSPECTIVES IN THE MANAGEMENT OF MALIGNANT NEOPLASMS [J].
BELANI, CP ;
DOYLE, LA ;
AISNER, J .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 :S118-S126
[4]   Polyamine-vectored iron chelators: The role of charge [J].
Bergeron, RJ ;
Bharti, N ;
Wiegand, J ;
McManis, JS ;
Yao, H ;
Prokai, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (12) :4120-4137
[5]   Terminally alkylated polyamine analogues as chemotherapeutic agents [J].
Casero, RA ;
Woster, PM .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (01) :1-26
[6]   Recent Advances in the Development of Polyamine Analogues as Antitumor Agents [J].
Casero, Robert A., Jr. ;
Woster, Patrick M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (15) :4551-4573
[7]   Probing the mechanism of transport and compartmentalisation of polyamines in mammalian cells [J].
Cullis, PM ;
Green, RE ;
Merson-Davies, L ;
Travis, N .
CHEMISTRY & BIOLOGY, 1999, 6 (10) :717-729
[8]   Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma [J].
Evageliou, Nicholas F. ;
Hogarty, Michael D. .
CLINICAL CANCER RESEARCH, 2009, 15 (19) :5956-5961
[9]  
Felschow DM, 1997, BIOCHEM J, V328, P889
[10]   Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole (NBD), rhodamine and bodipy as new fluorescent probes for the polyamine transport system [J].
Guminski, Yves ;
Grousseaud, Martial ;
Cugnasse, Sandrine ;
Brel, Viviane ;
Annereau, Jean-Philippe ;
Vispe, Stephane ;
Guilbaud, Nicolas ;
Barret, Jean-Marc ;
Bailly, Christian ;
Imbert, Thierry .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) :2474-2477